Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Aspart vs Lispro in Pediatric Insulin Pumps
NCT00097071Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Oct 2004
- Primary completion
- May 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin aspart in type 1 diabetes mellitus (T1D), sponsored by Novo Nordisk. Started Oct 2004; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00097071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00097071.